new glp 1 agonist novo nordisk Novo's Wegovy becomes first GLP-1 drug approved for MASH The rise of Ozempic maker

CVS Strikes a Deal to Offer Wegovy at a Discount

[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Stoker T

This hypothesized mechanism could enhance insulin secretion and suppress glucagon secretion in glucose-dependent manners (Figure 1)

In fact, the term GLP-1 drug itself is becoming somewhat restrictive as researchers create drugs targeting other incretin hormones

Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes

Tips for the transition Learn what happens when you stop taking a GLP-1 weight-loss drug and how to sustain results